Developer docs
API playgroundTry for free, no card

Search company profiles

Cord Blood Registry

Full company profile

uuid0008vni

Namestring
Cord Blood Registry
Legal namestring
Cord Blood Registry
Websiteurl
cordblood.com
Company typeenum
Private
Founded yearint
1992
Descriptiontext

Cord Blood Registry (CBR), founded in 1992 and headquartered in San Bruno, California, is the world's largest private newborn stem cell banking company. Its sole operational product is the collection, processing, and long-term cryogenic storage of umbilical cord blood stem cells from newborns, with the company's primary storage facility located in Tucson, Arizona holding more than 1 million samples. The business monetizes through an upfront enrollment fee plus recurring annual storage fees paid by individual families, making the revenue model predominantly subscription/recurring in nature. CBR serves U.S.-based expectant parents via direct-to-consumer digital advertising supplemented by healthcare provider referrals, marketing cord blood storage as a form of biological insurance with potential to treat 80+ medical conditions—a claim now contested by state regulators. CBR is one of the top five providers that collectively control over 54% of the consolidated cord blood banking market, and the company has been institutionally backed in the past by Essex Woodlands Healthcare Partners, ABS Capital Partners, and HLM Venture Partners, though no capital activity has been disclosed since 2002.

Short descriptiontext

Cord Blood Registry (CBR) is the world's largest private newborn stem cell bank, offering collection, processing, and long-term cryogenic storage of umbilical cord blood stem cells to U.S. expectant parents through a direct-to-consumer subscription model, with over one million samples stored at its Tucson, Arizona facility.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersSan Bruno, United States
HQ citystring
San Bruno
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cord blood banking, stem cell storage, newborn stem cells, cryogenic preservation, biomedical tissue storage
Industry2 codes
1Cell & Tissue Banking (biobanking, cord blood/tissue)
CodeHLAAAGAEPrimaryYes
2Blood Bank, Transfusion Medicine & Immunohematology
CodeHLAHAAAHPrimaryNo
NAICS code1 code
  • Blood and Organ Banks621991
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Cord Blood Banking Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Cord Blood Storage Services
TypeSubscription Recurring
Description

Annual cord blood storage services where families pay fees for collecting, processing, and storing their newborn's stem cells for potential future medical use.

usnews.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Infrastructure, Marketing or Sales, Personnel, Supply Chain, Technology or R&D
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Cord Blood Registry collects, processes, and cryogenically stores newborn umbilical cord blood stem cells for private family use. The company markets its service as a form of biological insurance, claiming preserved stem cells may be used to treat 80+ medical conditions. Storage takes place at its primary facility in Tucson, Arizona, which holds more than one million cord blood samples.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Only 19 transplants using a child's stored cord blood reported since 2010
Product overview1 text field

Cord Blood Registry (CBR) offers cord blood stem cell banking services as a single core product offering. The company provides private cord blood storage, collecting and preserving stem cells from newborns' umbilical cord blood for potential future medical use. CBR operates a storage facility in Tucson, Arizona, holding over one million cord blood samples.

Product and service1 record
1Cord Blood Storage
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

ViaCord (a PerkinElmer subsidiary) is one of the largest private cord blood banking companies in the US, directly competing with CBR for expectant-parent customers with the same subscription-based cord blood storage model.

TypeDirect peer
Description

Cryo-Cell International is a publicly traded cord blood banking company offering private and public cord blood storage services, directly competing with CBR for the same consumer segment with comparable subscription pricing.

TypeDirect peer
Description

Americord is a US-based private cord blood and tissue bank that markets directly to expectant parents, competing head-to-head with CBR on cord blood and cord tissue storage packages.

TypeDirect peer
Description

LifebankUSA is a private cord blood banking service operating in the same consumer-direct model as CBR, offering collection, processing, and long-term cryogenic storage of newborn stem cells.

TypeDirect peer
Description

StemCyte operates both private and public cord blood banking programs in the US, competing with CBR on private storage while also running a public registry — overlapping directly in private storage.

6FamilyCord
TypeDirect peer
Description

FamilyCord is a US private cord blood bank offering collection, processing, and storage services to expectant families, directly competing with CBR on consumer cord blood banking.

7New England Cord Blood Bank
TypeDirect peer
Description

New England Cord Blood Bank is a private cord blood banking facility that stores newborn stem cells for families, offering a comparable storage service to CBR's core product.

8China Cord Blood Corporation
TypeRegional player
Description

China Cord Blood Corporation is the dominant cord blood banking operator in China (with a Beijing municipality exclusive license), offering the same private storage service as CBR but geographically isolated from CBR's US-centric market.

TypeBroad incumbent
Description

Vitalant (formerly Blood Bank of America and others) is one of the largest US blood-collection nonprofit networks, operating broad public blood banking and transfusion services — adjacent to CBR's niche of private elective cord blood storage.

TypeEmerging player
Description

Cleveland Cord Blood Center is a public cord blood collection and banking center focusing on public-donation storage; it competes indirectly with CBR by offering expectant parents a free public-banking alternative to private storage.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cord Blood Registry

Cord Blood Banking Servicescordblood.com

Cord Blood Registry (CBR) is the world's largest private newborn stem cell bank, offering collection, processing, and long-term cryogenic storage of umbilical cord blood stem cells to U.S. expectant parents through a direct-to-consumer subscription model, with over one million samples stored at its Tucson, Arizona facility.

What Cord Blood Registry does

Cord Blood Registry (CBR), founded in 1992 and headquartered in San Bruno, California, is the world's largest private newborn stem cell banking company. Its sole operational product is the collection, processing, and long-term cryogenic storage of umbilical cord blood stem cells from newborns, with the company's primary storage facility located in Tucson, Arizona holding more than 1 million samples. The business monetizes through an upfront enrollment fee plus recurring annual storage fees paid by individual families, making the revenue model predominantly subscription/recurring in nature. CBR serves U.S.-based expectant parents via direct-to-consumer digital advertising supplemented by healthcare provider referrals, marketing cord blood storage as a form of biological insurance with potential to treat 80+ medical conditions—a claim now contested by state regulators. CBR is one of the top five providers that collectively control over 54% of the consolidated cord blood banking market, and the company has been institutionally backed in the past by Essex Woodlands Healthcare Partners, ABS Capital Partners, and HLM Venture Partners, though no capital activity has been disclosed since 2002.

Cord Blood Registry firmographics

Firmographics
Name
Cord Blood Registry
Legal name
Cord Blood Registry
Website
https://cordblood.com
Company type
Private
Founded year
1992
Operating status
Operating
Headcount range
251–500 employees
Short description
Cord Blood Registry (CBR) is the world's largest private newborn stem cell bank, offering collection, processing, and long-term cryogenic storage of umbilical cord blood stem cells to U.S. expectant parents through a direct-to-consumer subscription model, with over one million samples stored at its Tucson, Arizona facility.
Ownership category
akta.pro rank

Cord Blood Registry industry classification

Industry
Product category
Cord Blood Banking Services
NAICS
Blood and Organ Banks (621991)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro primary industry
Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)
akta.pro secondary industry
Blood Bank, Transfusion Medicine & Immunohematology (HLAHAAAH)

Keywords

  • Cord blood banking
  • Stem cell storage
  • Newborn stem cells
  • Cryogenic preservation
  • Biomedical tissue storage

Where Cord Blood Registry is headquartered

Location

Headquarters

HQ city
San Bruno
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Cord Blood Registry business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Operations, Infrastructure, Marketing or Sales, Personnel, Supply Chain, Technology or R&D

Revenue model

  1. Cord Blood Storage Services: Annual cord blood storage services where families pay fees for collecting, processing, and storing their newborn's stem cells for potential future medical use.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Cord Blood Registry product offering

Product offering

Core offering

Cord Blood Registry collects, processes, and cryogenically stores newborn umbilical cord blood stem cells for private family use. The company markets its service as a form of biological insurance, claiming preserved stem cells may be used to treat 80+ medical conditions. Storage takes place at its primary facility in Tucson, Arizona, which holds more than one million cord blood samples.

Product overview

Cord Blood Registry (CBR) offers cord blood stem cell banking services as a single core product offering. The company provides private cord blood storage, collecting and preserving stem cells from newborns' umbilical cord blood for potential future medical use. CBR operates a storage facility in Tucson, Arizona, holding over one million cord blood samples.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cord Blood Storage

Quantifiable outcome

  • Only 19 transplants using a child's stored cord blood reported since 2010

Companies that use Cord Blood Registry

Customer profile

Segments1 record

Ideal customer profiles1 record

Cord Blood Registry technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Cord Blood Registry partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Cord Blood Registry competitors and assessment

Company assessment

Direct peers

  • ViaCord: ViaCord (a PerkinElmer subsidiary) is one of the largest private cord blood banking companies in the US, directly competing with CBR for expectant-parent customers with the same subscription-based cord blood storage model.
  • Cryo-Cell International: Cryo-Cell International is a publicly traded cord blood banking company offering private and public cord blood storage services, directly competing with CBR for the same consumer segment with comparable subscription pricing.
  • Americord Registry: Americord is a US-based private cord blood and tissue bank that markets directly to expectant parents, competing head-to-head with CBR on cord blood and cord tissue storage packages.
  • LifebankUSA: LifebankUSA is a private cord blood banking service operating in the same consumer-direct model as CBR, offering collection, processing, and long-term cryogenic storage of newborn stem cells.
  • StemCyte: StemCyte operates both private and public cord blood banking programs in the US, competing with CBR on private storage while also running a public registry — overlapping directly in private storage.
  • FamilyCord: FamilyCord is a US private cord blood bank offering collection, processing, and storage services to expectant families, directly competing with CBR on consumer cord blood banking.
  • New England Cord Blood Bank: New England Cord Blood Bank is a private cord blood banking facility that stores newborn stem cells for families, offering a comparable storage service to CBR's core product.

Regional players

  • China Cord Blood Corporation: China Cord Blood Corporation is the dominant cord blood banking operator in China (with a Beijing municipality exclusive license), offering the same private storage service as CBR but geographically isolated from CBR's US-centric market.

Broad incumbents

  • Vitalant: Vitalant (formerly Blood Bank of America and others) is one of the largest US blood-collection nonprofit networks, operating broad public blood banking and transfusion services — adjacent to CBR's niche of private elective cord blood storage.

Emerging players

  • Cleveland Cord Blood Center: Cleveland Cord Blood Center is a public cord blood collection and banking center focusing on public-donation storage; it competes indirectly with CBR by offering expectant parents a free public-banking alternative to private storage.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Cord Blood Registry social profiles

Digital presence

Cord Blood Registry financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cord Blood Registry leadership team

Management profile

Number of profiles

Cord Blood Registry funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cord Blood Registry M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cord Blood Registry

What does Cord Blood Registry do?

Cord Blood Registry collects, processes, and cryogenically stores newborn umbilical cord blood stem cells for private family use. The company markets its service as a form of biological insurance, claiming preserved stem cells may be used to treat 80+ medical conditions. Storage takes place at its primary facility in Tucson, Arizona, which holds more than one million cord blood samples.

Is Cord Blood Registry a public or private company?

Cord Blood Registry is a private company. It is classified as venture growth investor backed and is currently operating.

When was Cord Blood Registry founded?

Cord Blood Registry was founded in 1992. It employs 251 to 500 people.

Where is Cord Blood Registry based?

Cord Blood Registry is headquartered in San Bruno, United States, in the North America region.

How does Cord Blood Registry make money?

One revenue line is on record: cord Blood Storage Services.

Who are Cord Blood Registry's main competitors?

Direct peers on record are ViaCord, Cryo-Cell International, Americord Registry, LifebankUSA, StemCyte, FamilyCord and New England Cord Blood Bank. China Cord Blood Corporation is listed as a regional player. Vitalant is listed as a broad incumbent. Cleveland Cord Blood Center is listed as an emerging player.

Does Cord Blood Registry have an API?

No public API is recorded for Cord Blood Registry.

What industry is Cord Blood Registry in?

Cord Blood Registry's product category is Cord Blood Banking Services. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue), with a secondary code of HLAHAAAH, Blood Bank, Transfusion Medicine & Immunohematology. Its NAICS code is 621991 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
UsnewsTwo States Sue Cord Blood Company Over Misleading ClaimsTexas and Arizona are suing cord blood storage company Cord Blood Registry (CBR), alleging the company made misleading claims to families about the medical benefits of storing their newborn's stem cells. The lawsuits, with officials seeking refunds for misled customers and removal of allegedly deceptive advertising, highlight that modern medicine has limited use for privately stored cord blood, with only 19 transplants using a child's stored cord blood reported since 2010. Federal inspectors have also found signs of bacterial growth at CBR's Tucson facility, which stores more than 1 million samples.The New York TimesTwo States Sue Cord Blood Bank Over False AdvertisementsTexas and Arizona attorneys general have filed separate lawsuits against Cord Blood Registry (CBR), alleging the company deceived families by marketing cord blood storage as a medical investment with the potential to treat 80+ conditions. CBR, which houses over one million cord blood samples in its Tucson, Arizona facility, faces claims that its advertisements are false since modern medicine rarely uses privately banked cord blood, citing a New York Times investigation that found only 19 self-donated cord blood transplants since 2010. State officials are seeking removal of CBR's deceptive advertisements and compensation for families who were misled, while a judge has already denied CBR's motion to dismiss the Arizona case.BioinformantUtilization of Umbilical Cord Blood in HSCT versus Regenerative Medicine (Percentage Breakdown)Umbilical cord blood utilization is shifting from traditional hematopoietic stem cell transplantation, which accounts for 83.7% of global market revenue, toward regenerative medicine applications comprising the remaining 16.3%. Companies such as Nohla Therapeutics, Gamida Cells, Angiocrine Bioscience, and BioIntegrate LLC are actively developing novel cellular therapies for conditions like spinal cord injury and diabetes, while Cord Blood Registry facilitates research by releasing stored units.PR NewswireChrissy Teigen Selects Cord Blood Registry® to Preserve Fourth Child's Newborn Stem CellsCooperSurgical announced that Chrissy Teigen selected Cord Blood Registry (CBR) to bank umbilical cord blood and cord tissue for her newborn Wren Alexander Stephens, who was born via gestational carrier in June 2023. CBR and Teigen jointly launched an educational campaign earlier this year to inform families using gestational carriers that newborn stem cell preservation remains a viable option for them. CBR is the largest family newborn stem cell preservation company in the world and operates as a wholly-owned subsidiary of CooperCompanies (NYSE: COO).PR NewswireChrissy Teigen Partners with Cord Blood Registry®CooperSurgical announced that Chrissy Teigen has partnered with Cord Blood Registry (CBR) on a multichannel educational campaign highlighting the benefits of banking newborn stem cells from cord blood and cord tissue.PR NewswireGenerate Life Sciences' Cord Blood Registry (CBR®) has helped 10,000 Families enroll in its Newborn Possibilities Program (NPP)Generate Life Sciences announced that its Cord Blood Registry (CBR) has surpassed 10,000 families enrolled in the Newborn Possibilities Program (NPP), which provides umbilical cord preservation and access to stem cell therapies for children diagnosed with serious conditions or born with low Apgar scores. The milestone highlights the company's role in connecting families to traditional transplant therapies and regenerative medicine clinical trials. The announcement includes a personal success story of a sickle cell patient who received transplant therapy using her brother's preserved cord stem cells and is now healthy 13 years later.PR NewswireGenerate Life Sciences' Cord Blood Registry (CBR®) Enrolls 200,000 Families in its Family Health RegistryGenerate Life Sciences announced that its Cord Blood Registry (CBR) has enrolled 200,000 families in its Family Health Registry, which connects families who have banked newborn stem cells with active clinical trials researching these cells for therapeutic use. Of these enrollees, 36,000 immediate family members (nearly 20%) have been identified as potential beneficiaries of existing or emerging treatments using banked stem cell units. The registry also facilitates Generate's longitudinal LUSTRE study, which has enrolled nearly 3,000 families and is still actively recruiting participants to study conditions including cerebral palsy and autism.PR NewswireGlobal Stem Cell Banking IndustryThe global stem cell banking market is projected to reach US$9.9 billion by 2025, driven by the growing importance of stem cells in regenerative medicine for treating chronic diseases such as diabetes, heart disease, and Parkinson's. The United States and Europe together account for 60.5% of the market, while China represents the fastest-growing region with a CAGR of 10.8%, supported by government initiatives including the 2008 Developmental and Reproductive Research Initiation program. Key industry players identified include Cord Blood Registry, Cryo-Cell International, Global Cord Blood Corporation, Vita34 AG, and others competing in the cord blood banking sector.PR NewswireCord (Stem Cell) Blood Banking Market to Grow at a CAGR of 11.6% During 2018-2022 Report by TBRCThe Business Research Company reports that the global stem cell and cord blood banking market is projected to grow from $6.96 billion in 2018 to $10.79 billion by 2022, driven by increasing cancer treatments via transplants. Key players such as GI Partners, AMAG Pharmaceuticals, and Cord Blood Registry are actively expanding through mergers and acquisitions, with GI Partners acquiring CBR for $530 million in June 2018.PR NewswireGolub Capital Provides $450 Million Financing to Support the Acquisitions of California Cryobank and Cord Blood Registry by GI PartnersGolub Capital provided $450 million in senior credit facilities to support GI Partners' acquisitions of California Cryobank and Cord Blood Registry, which will be combined under the California Cryobank Life Sciences platform. The combined company will operate from Los Angeles with facilities in Tucson, Arizona, and branches across multiple U.S. cities, positioning itself as a market leader in donor reproductive tissue and newborn stem cell storage services. The new platform aims to pursue domestic and international expansion, having already served nearly 700,000 families across more than 30 countries.